diallyl trisulfide has been researched along with Colitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dai, Y; Guo, Y; Wei, Z; Xia, Y; Zhang, Q; Zhang, Y; Zhu, Y | 1 |
Choi, KS; Lee, HG; Lee, HJ; Na, HK; Surh, YJ | 1 |
2 other study(ies) available for diallyl trisulfide and Colitis
Article | Year |
---|---|
Diallyl Trisulfide, a Major Bioactive Constituent of Garlic, Promotes Colonic Mucosal Healing in Ulcerative Colitis through Accelerating Focal Adhesion Assembly and Consequent Epithelial Cell Migration via the Rab21-Integrin β1-Fak Pathway.
Topics: Animals; Cell Movement; Colitis; Colitis, Ulcerative; Epithelial Cells; Female; Focal Adhesion Protein-Tyrosine Kinases; Focal Adhesions; Garlic; Integrin beta1; Mice; Mice, Inbred C57BL | 2023 |
Diallyl trisulfide suppresses dextran sodium sulfate-induced mouse colitis: NF-κB and STAT3 as potential targets.
Topics: Allyl Compounds; Animals; Colitis; Dextrans; Mice; NF-kappa B; STAT3 Transcription Factor; Sulfides | 2013 |